Organizer
Phenomenex
Phenomenex
Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, government and academic laboratories. From drug discovery and pharmaceutical development to disease diagnosis, food safety to environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve global health and well-being.

Phenomenex at ASMS 2026

30. May - 3. June 2026
Join this Phenomenex ASMS breakfast seminar to learn how advanced LC column design improves LC-MS/MS uptime, robustness, and performance in high-throughput workflows.
For more information click here
Phenomenex at ASMS 2026

Chromatography Innovation, Delivered.

BREAKFAST SEMINAR: Achieving Longer LC‑MS/MS Uptime with Advanced Column Design

  • Tuesday, June 2nd
  • 7:00 AM - 8:15 AM
  • San Diego Convention Center, Room 33C
  • Frances Morris, MS (Lead Product Development Scientist, Molecular Testing Labs)

HPLC column durability is essential for laboratories running high-throughput, multi-analyte LC-MS/MS workflows. In this seminar, Endrix Kinetex columns, designed with innovative hardware to extend column lifetime, are compared to standard Kinetex columns. A comprehensive 75 analyte urine toxicology panel was used to demonstrate how advanced hardware design improves longevity, robustness, and increases uptime.

Reserve your seat

Find us at the SCIEX Hospitality Suite
  • Pacific Ballroom 18 & 19
  • Marriott Marquis San Diego Marina

Experience our products, and enjoy entertainment starting at 8:00 PM each night.

POSTER SESSIONS

  • 10:30 AM - 2:30 PM
  • JUNE 1 - 4

Meet our scientific experts and learn about the latest advances in separation science with insights you can apply directly to your lab.

Systematic LC Method Development: A Case Study on Mupirocin
  • Jenny Lewis, Global Marketing, Phenomenex
Practical LC-MS Analysis of NDSRIs Using Biphenyl Selectivity
  • Vikram Shenoy, PhD, Business Development, Phenomenex
Evaluation of Inert Chemical Vapor Deposition Coatings on Column Hardware for Liquid Chromatography-Mass Spectrometry Applications
  • Brady Drennan, PhD, Scientist, Research and Open Innovation, Phenomenex
Size Exclusion Coupled with Mass Spectrometry (SEC-MS) for Early OAR Characterization of Antibody – Oligonucleotide Conjugates (AOCs)
  • Jeremy Primack, Business Development, Phenomenex
Overcoming Sensitivity and Recovery Challenges in Quantitation of Conjugated Oligonucleotide Therapeutics Using Clarity OTX Pro SPE Kits
  • Tran Pham, MBsc, Senior Market Development Manager, Biopharma
LC-MS/MS Analysis of Ultra-short Chain PFAS in Tomatoes Using a LunaPolar Pesticides HPLC Column
  • Mihir Thakar, MS, Global Product Management, Phenomenex
A LC-MS Ready Size Exclusion Chromatographic Platform Method for Oligonucleotide and mRNA Identification
  • Crystal Holt, MS, Senior Director, Global Marketing & GC Business Unit Manager, Phenomenex
Optimization of Chromatographic Resolution of Individual DAR Species in Native RPLC-HRMS Rapid Characterization of Antibody Drug Conjugates
  • Carl Sanchez, BSc, Principal Scientific Advisor, R&D, Phenomenex
Systematic GC Method Development: A Case Study on Pesticide Residues
  • Ross Salzberg, HPLC Account Manager, Phenomenex
Comparative Lifetime Evaluation of Kinetex Endrix vs. Standard Kinetex Columns for a Pain Management Drugs Panel Analysis by LC-MS/MS
  • Rajashree Chakravarti, PhD, Global Product Management, Phenomenex
Characterizations of Antibody Oligonucleotide Conjugates Utilizing Robust SEC and IEX LC Separations and UV, MALS and MS Detection Strategies
  • Shilin Cheung, PhD, Scientist, Phenomenex
Credibility in Modern Science: How Researchers Can Evaluate What to Trust
  • Amy Nguyen, Global Marketing, Phenomenex
Size Exclusion Coupled with Mass Spectrometry (SEC-MS) for Early OAR Characterization of Antibody–Oligonucleotide Conjugates (AOCs)
  • Roxana Eggleston MS, Senior Application Scientist, Phenomenex
Methylmalonic Acid in Serum by LC-MS/MS for Clinical Research Using Supported Liquid Extraction
  • Haroon Rehmani, Clinical/Forensic Toxicology, Phenomenex
Phenomenex
LinkedIn Logo
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike